戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  cognitive control (i.e., stimulus preceding negativity).
2 tients who are defined as having imaging MRD negativity.
3 cal to the primary diagnosis except for CD19 negativity.
4  responded achieved minimal residual disease negativity.
5 d potentials (LF-ERPs), such as the mismatch negativity.
6 d blood-culture positivity, or blood-culture negativity.
7                  All cases showed p53 immuno-negativity.
8 itive as collaterally determined by mRNA ISH negativity.
9 34 patients (76%, 95% CI 62-89) achieved PET-negativity.
10 sion-free survival in patients achieving MRD negativity.
11 l Cox regression to analyse time to antibody negativity.
12  derived that determined nodal positivity or negativity.
13 ous other community preferences unrelated to negativity.
14 rrant full-thickness CK17 positivity and CK7 negativity.
15 ca because of the protective effect of Duffy negativity.
16 y normal controls used as a standard for tau negativity.
17 icity, 6.6% false positivity, and 4.8% false negativity.
18 , potentially reflecting adaptation to Duffy negativity.
19 e N200, P300/N400, and phonological mismatch negativity.
20  investigate potential reasons for PET false negativity.
21 4%) of 542 achieved minimal residual disease-negativity (10(-5) sensitivity threshold, assessed by mu
22 0177), as did minimal residual disease (MRD) negativity (10-5 threshold) rates in the intent-to-treat
23  day 5 viral RNA (44.7% vs 40.2%) or culture negativity (100.0% vs 98.1%), RNA decline rate, and dura
24 ependent predictive factor affecting HCV RNA negativity 6 months after liver transplantation (OR:11.2
25 ns showed false positivity (59.1%) and false negativity (8.3%) in ARFI US.
26 ssion-free survival (45%) compared with PET2 negativity (81%, P < 0.002), DeltaSUVmax (>71 vs </=71%)
27 gher HR for developing MS compared to double negativity (95% CI = 12.26-58.74, p < 0.001).
28 rning from mistakes (i.e., the error-related negativity), a putative index of prediction error signal
29                      Likewise, error-related negativity, a marker for error processing, was greater i
30 ion between hexokinase-2 expression and this negativity: a finding which may also be relevant for cli
31 ion as reflected by reduced feedback-related negativity (ADHD, 0.61 [3.90] muV; controls, -1.68 [2.52
32                                     Mismatch negativity amplitude (F = 4.39, P = .04) and glutamate (
33 asured the amplitude of the feedback-related negativity, an event-related brain potential associated
34 characterized by an early (200 ms) posterior negativity and a later (>300 ms) parietal positivity in
35 st-person perspective enhanced error-related negativity and medial-frontal theta power in the trials
36                                 The mismatch negativity and P300 components of the auditory event-rel
37 ing (N2) and error processing (error-related negativity and positivity) from an arrow flanker task wi
38 osed sialic acids reduces macrophage surface negativity and severely impairs directional migration of
39                           Both the nature of negativity and the liberal-conservative opposition are a
40 is associated with the magnitude of mismatch negativity and, critically, is impaired in healthy peopl
41 67 >20%, age <=35 years, or hormone receptor negativity), and randomly assigned them to adjuvant anth
42  Group performance status of 2 or lower, HIV negativity, and absence of comorbidity disallowing proto
43  have been analyzed by skew information, log-negativity, and Bell function quantifiers.
44 rs, reaction time variability, error-related negativity, and error-related positivity (all p </= .05)
45 an epidermal growth factor receptor 2 (HER2) negativity, and histologic grade 1 in luminal A tumors.
46 activator inhibitor-1, hormone receptor (HR) negativity, and less than 35 years of age.
47  refractory Hodgkin's lymphoma achieving PET-negativity, and therefore could optimise the chance of c
48 ssayed by 3,3'-dihexyloxacarbocyanine iodine negativity, annexin positivity, and poly (adenosine 5'-d
49 bsequent ERP component, the visual awareness negativity ( approximately 260-300 ms), were absent duri
50 mong the measures studied, P300 and mismatch negativity are notable because deficits predict conversi
51 ly those classically termed feedback-related negativity, are modulated by both the reward level and s
52            Error-related and correct-related negativity as electrophysiological indicators of perform
53 olecular features, such as estrogen receptor negativity as well as HER2-enriched and basal-like PAM50
54 ation between electromechanical window (EMW) negativity, as derived from echocardiography, and sympto
55  the minimized total dwell time with its non-negativity at each dwell point.
56 greater proportion of patients achieving MRD negativity at EOT (56% vs 41%; P = .01).
57  to establish the exposure necessary for GMI negativity at the end of therapy.
58 and impact on minimal residual disease (MRD) negativity because this end point has been associated wi
59 stent with the previously reported increased negativity bias after insufficient sleep.The Stockholm s
60  into account both individual differences in negativity bias and differences in empathic concern.
61 nditional nature of the relationship between negativity bias and ideology by arguing that the politic
62 he analysis of individual differences in the negativity bias and political ideology.
63  suggest that relations between ideology and negativity bias are linear.
64       We argue that the political effects of negativity bias are narrower than Hibbing et al. suggest
65         In our target article we argued that negativity bias can explain a surprisingly large share o
66               Value conflicts that represent negativity bias clarify differences between what worries
67 ess reactivity is associated with a stronger negativity bias during ambiguous affective decision-maki
68                                              Negativity bias explains many ideological differences, y
69 group psychology more generally; we observed negativity bias for estimation of out-group, anonymized-
70       The commentators generally support the negativity bias hypothesis but suggest theoretical and e
71                             Thus the role of negativity bias in broad ideological conflict depends on
72                                         This negativity bias in group meta-perception was present acr
73                                          The negativity bias in human cognition emerges in infancy an
74 hat the difference across individuals in the negativity bias is a key factor in determining political
75                                              Negativity bias may underlie the development of politica
76                                              Negativity bias reliably predicts social, but not econom
77 logy by arguing that the political impact of negativity bias should vary as a function of (1) issue d
78 san meta-perceptions are subject to a strong negativity bias with Democrats and Republicans agreeing
79 induction and measuring trait differences in negativity bias within VR.
80 riers in three behavioral domains, that is, 'negativity bias' (negative valence), 'apathy' (arousal)
81 ferences points not to global differences in negativity bias, but to differences in threat bias, prob
82                                              Negativity bias, i.e., tendency to respond strongly to n
83      There is an extensive literature on the negativity bias, including its conceptualization, measur
84 in are those likely to reflect the degree of negativity bias.
85 le psychological factor, namely, strength of negativity bias.
86 s may be rooted in individual differences in negativity bias.
87 dict one major prediction from the authors' "negativity-bias" model.
88  our results make clear the pervasiveness of negativity biases on average, they help account for the
89 omprehensive cross-national demonstration of negativity biases to date, but they also serve to highli
90                                             "Negativity biases" in human cognition and behavior are w
91 mportance of genetic and cultural factors on negativity biases.
92 f shapes was indexed by the visual awareness negativity but not a P3.
93 state and fully characterize its logarithmic negativity by homodyne tomography.
94 itivity was associated with hormone receptor negativity (chi(2) P < .001) and nodal positivity (chi(2
95  those who achieved CSF cryptococcal culture negativity compared to those with positive cultures pre-
96 y enhanced error-related and correct-related negativity compared with healthy comparison subjects.
97 ude of the sustained posterior contralateral negativity component (SPCN, 300-400 ms) decreased, indic
98 propose a framework based on alternating non-negativity-constrained least squares which accounts for
99                              Without the non-negativity constraint, the output converges to a square
100                                          MRD negativity correlated with both progression-free surviva
101               Minimal residual disease (MRD) negativity, defined as <1 chronic lymphocytic leukemia (
102                                     Mismatch negativity did not significantly differentiate ESZ and C
103                                     "Culture negativity" does not seem to be due to failure of growth
104 oencephalographic recordings of the mismatch negativity elicited in a large cohort of human subjects,
105 lection is the N2pc, a lateralized posterior negativity emerging around 180-200 ms.
106 mans have established larger early posterior negativity (EPN) in response to pictures depicting snake
107 with the P2 and encompassing early posterior negativity (EPN), P3, and the late positive potential (L
108 to motivational salience-the Early Posterior Negativity (EPN), reflecting earlier selective attention
109 itch deviants evoked an early right anterior negativity (ERAN) in both groups.
110 ssing and coupling between the error-related negativity (ERN) and consecutive behavioural slowing.
111 nce monitoring, indexed by the error-related negativity (ERN) and manifested by performance adaptatio
112 es of error processing, namely error-related negativity (ERN) and positivity.
113 monitoring, as measured by the error-related negativity (ERN) in the event-related potential, is a re
114                            The error-related negativity (ERN) is a well-established macroscopic scalp
115 areness studies found that the error-related negativity (ERN), an event-related potential (ERP) origi
116 rmance monitoring, such as the Error-Related Negativity (ERN), are considerably influenced by situati
117 monitoring, as measured by the error-related negativity (ERN), is a transdiagnostic neurobiological m
118 lus-locked P2, response-locked error-related negativity (ERN/Ne), and response-locked error positivit
119 etection (the latter indexed by the mismatch negativity event-related potential) relies on probabilit
120  12 months of ibrutinib plus venetoclax, MRD negativity (fewer than one CLL cell in 10,000 leukocytes
121               The feedback- or error-related negativity (FN) has been extensively documented in front
122  we studied as a measure of RPE the feedback negativity (FN) that is sensitive to both reward and the
123 vent-related potential, the feedback-related negativity (FN), is evoked over the ACC whenever expecta
124  IgE test (ImmunoCAP((R))) showed absolutely negativity for all suspected foods.
125 n overt PMF (7.2 vs 17.6 years), with triple negativity for driver mutations and presence of HMR muta
126 ositivity for vascular endothelium and D2-40 negativity for lymphatic endothelium.
127                                  An enhanced negativity for the /pt/ cluster relative to its contrast
128  and a neural modulation of feedback-related negativity (FRN) and stimulus-preceding negativity (SPN)
129 justment: the frontocentral feedback-related negativity (FRN) and two P300 (P3) subcomponents, the fr
130          Modulations of the feedback-related negativity (FRN) event-related potential (ERP) have been
131  data demonstrated a larger feedback-related negativity (FRN) in response to money loss during risk t
132                         The feedback-related negativity (FRN) is a commonly observed potential in sca
133                         The feedback-related negativity (FRN) is a neural response that in part refle
134 contingencies modulated the Feedback-Related Negativity (FRN), a human brain potential known to index
135 ents, including the P2, the feedback-related negativity (FRN), and the late positive component (LPC),
136 eration of this ERP and the feedback-related negativity (FRN), often assumed to reflect reward-predic
137 ll studied in humans is the feedback-related negativity (FRN), which is assumed to indicate activatio
138 N1), motivational salience (feedback-related negativities [FRN]), and cognitive appraisal (P300) stag
139 29), automatic auditory processing (mismatch negativity), g = -0.44, 95% CI (-0.66, -0.22), and perfo
140 ), and performance monitoring (error-related negativity), g = -0.56, 95% CI (-0.79, -0.33).
141 ensory measures, including impaired mismatch negativity generation (r=0.62, N=51, p=0.0002).
142 ency response (P < 0.05); and (iii) mismatch negativity generation to trained versus untrained tones
143    Multivariate analysis identified that HPV negativity (hazard ratio [HR], 2.9; 95% CI, 2.0 to 5.0),
144 tor receptor 2 positivity, estrogen receptor negativity, high tumor grade, and large tumor size.
145                A genome-wide analysis of TST negativity identified a significant linkage signal (P <
146 teractions and is unambiguously indicated by negativities in the phase-space quasi-probability distri
147 Conclusion: Beyond HK2 expression, (18)F-FDG negativity in (mainly pretreated) MM patients seems to b
148                             We detected ASS1 negativity in 40% of bladder cancers, in which multivari
149  was to describe the proportion of PET false-negativity in a representative set of 227 newly diagnose
150  log10 reduction >= 3 and achievement of MRD negativity in BM and PB were significantly associated wi
151    The hazard ratios for the time to culture negativity in both solid and liquid mediums for the ison
152            Analysis of overall sentiment and negativity in comment text was performed using the Valen
153 tolerable and demonstrates high rates of MRD negativity in NDMM, translating into longer progression-
154 compared to controls, with more profound EMW negativity in patients with symptomatic LQTS compared to
155        They were concordant with IED surface negativity in seven of eight patients (0.88; 95% confide
156                            The time to virus negativity in stool was determined.
157 ivity in hERG K(+) channel blockage testing, negativity in the Ames test, and 5/5 cure @ <15 mpk x 3
158 d terminal deoxynucleotidyltransferase (TdT) negativity in the BPDCN cells.
159 monitoring, as measured by the error-related negativity in the event-related brain potential, represe
160 es elicited a larger frontocentral sustained negativity in the evoked potential as well as enhanced p
161 t for full-thickness CK14 positivity and CK7 negativity in the lesion.
162  collapse were closely associated with smear negativity in this age group.
163 sing was associated with the visual mismatch negativity independently of consciousness and task relev
164                       HR-HPV- and dual stain-negativity indicate a low risk of HSIL/AIN2+ for at leas
165  The EFS hazard ratio (HR) for achieving MRD negativity is 0.23 (95% Bayesian credible interval [BCI]
166                                 The mismatch negativity is a potential biomarker of schizophrenia and
167 opped until clinical recovery and SARS-CoV-2 negativity is established and treatment with biologicals
168 lantation (18)F-fluorodeoxyglucose (FDG) PET-negativity is one of the strongest predictors of outcome
169             The value of having achieved MRD negativity is substantial in both pediatric and adult pa
170                                        HBeAg negativity is thus an ancient HBV infection pattern, whe
171 ndex of cognitive control, the error-related negativity, is investigated to examine its suitability a
172                                         This negativity lasts for hundreds of milliseconds and it has
173  decrease in ERP amplitude of a late frontal negativity (LFN) elicited by the isolated word.
174                      In our case, the HMB-45 negativity may be explained by the rarity of the epithel
175                      A reduced error-related negativity measured during the first week of treatment w
176 d that the amplitude of the feedback-related negativity, measured as the difference wave in the event
177 ion between functional outcomes and mismatch negativity (MMN) activity in participants with mood diso
178 nt-related potential studies as the mismatch negativity (MMN) and has been observed in several sensor
179 in, the focus is on sensory gating, mismatch negativity (MMN) and P300, thereby discussing which para
180                    For example, the mismatch negativity (MMN) and P3a event-related potentials (ERPs)
181 teady-state stimulation, as well as mismatch negativity (MMN) and P3a event-related potentials.
182               EEG measures of EAIP, mismatch negativity (MMN) and P3a, are sensitive to the neural sy
183 ed event-related potential known as mismatch negativity (MMN) and provides a potential link between n
184               Here, we examined the mismatch negativity (MMN) component of the event-related potentia
185 icits in the generation of auditory mismatch negativity (MMN) generation are among the most widely re
186 processing: prepulse inhibition and mismatch negativity (MMN) in SZ patients and healthy subjects (HS
187                                     Mismatch negativity (MMN) indexes pre-attentive information proce
188                            Auditory mismatch negativity (MMN) is a biomarker for schizophrenia though
189                                 The mismatch negativity (MMN) is a brain event-related potential mark
190                                 The mismatch negativity (MMN) is an event related potential evoked by
191                                     Mismatch negativity (MMN) is an extensively validated biomarker o
192                The observation that mismatch negativity (MMN) is consistently impaired in schizophren
193                        The auditory mismatch negativity (MMN) is significantly reduced in schizophren
194 n elicit an electroencephalographic mismatch negativity (MMN) response.
195  discrimination ability [indexed by mismatch negativity (MMN) responses].
196 rison subjects (NCSs) who underwent mismatch negativity (MMN) testing via their participation in the
197                                     Mismatch negativity (MMN) to FM tones was assessed in 43 patients
198  was conducted to determine whether mismatch negativity (MMN), an event-related potential index of au
199                                     Mismatch negativity (MMN), an evoked potential calculated by subt
200  had developed PTSD showed enhanced mismatch negativity (MMN), increased theta power (5-7 Hz), and st
201 signatures of neurodynamics, namely mismatch negativity (MMN), P300, and contingent negative variatio
202  paradigms were presented to derive mismatch negativity (MMN), which reflects the ability to automati
203 ctroencephalogram (EEG) paradigm of mismatch negativity (MMN).
204 se inhibition (PPI) of startle) and mismatch negativity (MMN).
205 tes evoked responses--including the mismatch negativity (MMN).
206 e-head electrical recordings of the mismatch negativity (MMN).
207 uptions on auditory discrimination (mismatch negativity; MMN) responses to phoneme and tone changes i
208 ars; n = 23) showed age-appropriate mismatch negativities (MMNs) to sounds, but older children (12-16
209 anscript levels (TLs) and achievement of MRD negativity (MRD-) for impact on prognosis.
210 of MFC activity on errors, the error-related negativity (Ne/ERN), in a task in which two types of err
211        Overall, 68% of patients achieved MRD negativity; none of these patients relapsed.
212 We show that this improvement stems from the negativity of a particular quasiprobability distribution
213  correlations corresponding to a logarithmic negativity of E(N) = 0.35.
214          We suggest that reduction in charge negativity of MWNT-antigen conjugate enhances cellular u
215 logy was used to determine the positivity or negativity of PD-1/PD-L1.
216 f OA and WEA was based on the positivity and negativity of results on specific inhalation challenges,
217 both the non-linear combination rule and non-negativity of the data.
218 (20-30 Hz) frequencies and fired at the peak negativity of the field oscillation.
219          For three clinical specimens, false negativity of the gold standard assay could not be exclu
220 s because they (1) are uncorrelated with the negativity of the stimuli being considered, (2) do not r
221  However, OPT should be performed in case of negativity on skin tests.
222 definition of these cells that also includes negativity or low level of expression of CD127.
223 was associated with older age, smoking, node negativity, or prior thromboembolic event.
224 ency (p = .644), Infrequency (p = .097), and Negativity (p = .456) were not statistically significant
225 emphasis and found that the feedback-related negativity, P300, and late positive potential could coll
226          Main Outcome and Measures: Mismatch negativity, P3a, and reorienting negativity were used to
227                    Simulations of a mismatch negativity paradigm predicted a rapid trial-by-trial sup
228 s of processing: the posterior contralateral negativity (PCN) was used to index focal-attentional sel
229 ested that there is a connection between TST negativity per se and TNF production.
230 le, that controls tuberculin skin test (TST) negativity per se, that is, T-cell-independent resistanc
231 f the HR hybrid method itself, and sometimes negativity phenomena may even improve the accuracy.
232 iological signatures: an early left anterior negativity post code switch onset - a LAN - followed by
233   50.7% of patients with IGHV-M achieved MRD-negativity posttreatment; of these, PFS was 79.8% at 12.
234  stimulation eliciting the cortical mismatch negativity potential demonstrate deficits in early senso
235 w effect), as well as a sustained widespread negativity, potentially indicative of memory searches fo
236                            Conversion to PCR negativity predicted better progression-free survival (P
237 iveness such as high grade, hormone receptor negativity, presence of a basal-like or TNBC phenotype a
238                   This work investigates the negativity problem of the HR hybrid method, analyzes and
239 mstances, three remedies are studied for the negativity problem.
240                     In addition: (iii) early negativities (RAN effects), which previous work has conn
241 d interferon alpha (PEG-IFNa) showed HDV RNA negativity rates of 25-30% 24 weeks after therapy.
242 demonstrated superior circumferential margin negativity rates with LP compared with OP (odds ratio 1.
243 intracortical homolog of the "object-related negativity" recorded noninvasively in humans, which corr
244 trate the long-term benefit of achieving MRD negativity, regardless of the therapeutic setting and tr
245        None of the patients who achieved MRD negativity relapsed.
246 04 and 0.8 +/- 0.03 for nodal positivity and negativity, respectively).
247 ing with their full-thickness positivity and negativity, respectively, in normal conjunctival epithel
248            Patients showed impaired mismatch negativity response to emotionally relevant frequency mo
249 d index of auditory perception, the mismatch negativity response, tested whether the therapies altere
250 oral networks, including an evoked 'mismatch negativity' response and transiently induced oscillation
251        EEG recordings revealed that mismatch negativity responses were larger for timing deviants of
252             Electroencephalographic mismatch negativity responses, which quantify the violation of se
253 , while bipolar probands scored higher on a "negativity" scale compared with their co-twins and contr
254                                              Negativity scores in posts describing cancellations were
255                                          MRD negativity should be considered as one of the most relev
256         Nevertheless, both P300 and mismatch negativity show promise as electrophysiological markers
257 elated potentials, such as the error-related negativity.SIGNIFICANCE STATEMENT A minimal model of lay
258                             Furthermore, MRD negativity significantly improved TTP of patients >75 ye
259 erceptual training improved the EEG mismatch negativity significantly more than executive training im
260 uted multivoxel pattern reflecting affective negativity) simulated the presumed affective state of th
261 ated negativity (FRN) and stimulus-preceding negativity (SPN) following outcome value modulation.
262 s and it has been called sustained posterior negativity (SPN).
263 l response shares similarities with mismatch negativity, suggesting the involvement of anterior cingu
264 atial and temporal features as error-related negativity, the electrophysiological correlate of perfor
265 nclude task-based fMRI (RISE task), mismatch negativity, the Scale for the Assessment of Negative Sym
266                                     Mismatch negativity to auditory deviants (duration, frequency, an
267          We found the incidence of PET false-negativity to be 11%.
268  obesity was associated with weaker implicit negativity toward overweight people compared to thin peo
269 besity was associated with stronger implicit negativity toward overweight people compared to thin peo
270 f personal obesity is associated with weaker negativity toward overweight people on both explicit (i.
271  people consistently overestimated out-group negativity towards the collective behaviour of their in-
272 ess by which early individual differences in negativity unfold and are shaped by both genes and envir
273 automated method, amyloid-beta positivity or negativity using a standardised uptake value ratio appro
274   The rate of minimal residual disease (MRD) negativity using modified ITT was 70% according to next-
275 genetics, with prognostic superiority of MRD negativity versus CR particularly evident in patients wi
276 uthors connect conservatism with aversion to negativity via the tendentious use of the language of th
277 erse-transcription polymerase chain reaction negativity was 46.4 days after symptom onset (95% confid
278 th resistant virus, the median time to virus negativity was 5.5 days in pocapavir recipients, compare
279                  Moreover, the error-related negativity was a stronger predictor of recent cocaine us
280                                         ANCA negativity was associated with a decreased proportion of
281                                         ANCA negativity was associated with an increased proportion o
282  in the word-matching task, while a parietal negativity was elicited by semantically unrelated primes
283 eving at least a near-complete response, MRD negativity was found in 28 of 28 (100% [95% CI, 88%-100%
284                             Time to antibody negativity was longer in patients with relapses (HR 0.18
285                            The error-related negativity was measured in 57 cocaine-dependent patients
286 omplete remission (CR) in the absence of MRD negativity was not associated with prolonged progression
287         The greatest impact of achieving MRD negativity was seen in patients receiving frontline trea
288                            The error-related negativity was the only significant predictor in the mod
289                                     Mismatch negativity was used as a functional read-out of auditory
290 f valence bias, is associated with increased negativity, we tested how individual differences in acut
291 and Kaplan-Meier curves for time to antibody negativity were performed for the objectives.
292 s: Mismatch negativity, P3a, and reorienting negativity were used to measure EAP.
293 ral evoked response similar to error-related negativity, which has in turn been implicated in general
294           The mutation responsible for Duffy negativity, which impedes Plasmodium vivax infection, ha
295                                      MFC-MRD negativity, which was achieved in 51% of patients after
296                We identified a frontocentral negativity whose amplitude was modulated by the size of
297 cent studies suggest that achievement of MRD-negativity with blinatumomab improves outcomes in patien
298 y ClonoSeq achieved minimal residual disease negativity with CLL <1/10 000 white blood cells, which p
299    CHB patients with HVL can achieve HBV DNA negativity with long-term TDF treatment, although time t
300 ponse categories of minimal residual disease negativity, with or without imaging-based absence of ext

 
Page Top